Vivamed Sp. z o.o.
- Address
- Ul. Zamiejska 17, 03-580 Warsaw, Poland
Digestive System Diseases
At Vivamed Sp. z o.o. in Warsaw, investigators are concentrating on inflammatory bowel conditions, seeking to improve outcomes for patients with moderately to severely active ulcerative colitis and Crohn's disease.
- Combination therapy with biologic agents
- Evaluation of new oral small‑molecule treatments
- Clinical remission assessment using standardized scores
These efforts integrate gastroenterology expertise with innovative therapeutic strategies to enhance patient quality of life.
Immune System Diseases
The clinical program explores immune‑mediated pathways that drive bowel inflammation, testing novel methods to modulate the immune response in severe disease.
- Targeting interleukin signaling pathways
- Dual‑target biologic regimens
- Placebo‑controlled studies of remission rates
The goal is to expand therapeutic options for patients whose disease remains active despite conventional treatments.
Site Overview
Activity Indicator
Last 6 months
Trial Flow
How this site's trials are distributed across therapeutic areas and active substances (IMPs), and how they're positioned within their overall lifecycle status. Flow thickness represents the number of unique trials.
Compounds & Molecules Timeline
The time span of clinical-trial activity for the main active substances (IMPs) studied at this site over the last 8 years. Each bar runs from the earliest trial start to the most recent end; a substance with a trial still open has no recorded end and is shown as ongoing.
Sponsor & Partnership
Top sponsors by active trials, and the ones that have come back for more than one study.
Sponsor Network
Top 1 by active trials.
- 1Merck Sharp & Dohme LLC1active
Partnership History
Sponsors with repeated collaboration (≥ 2 trials).
- 1Janssen Cilag International2trials
Sponsor Network Graph
How sponsors and therapeutic areas connect across this site's active trials: each link is at least one active trial shared between them, and bigger nodes mean more activity. Click a node to see its exact connections.
Country Benchmark
Compared to 1 710 other sites in Poland
Therapeutic Area Benchmark — Poland
Select a therapeutic area to compare against other sites in Poland.
Competitor Comparison
Similar sites in the same country running a comparable number of trials (within ±30%), scored on how closely their trial portfolios match this one. Higher percentages mean a more similar profile.
Country: Poland
Market Share
Country: Poland
Therapeutic Area Market Share
Select a therapeutic area to view its disease coverage breakdown.
Heat Maps & Advanced Analytics
How often specific conditions appear in trials across this site and comparable sites from the same country. Each row is a site, each column a condition, and each cell the number of trials on it — darker means more activity.
Other Trials in Vivamed Sp. z o.o.
lock Showing 1 of 3 trials — the rest is available on a paid plan.
| Trial | Sponsor | Phase | Status | Start Date | End Date |
|---|---|---|---|---|---|
| Efficacy and Safety Evaluation of Guselkumab and Golimumab Combination Therapy in Moderate to Severe Crohn's Disease: A Phase 2b Randomized Controlled Trial | Janssen Cilag International | Phase II | Not Recruiting | Nov 2022 | — |
IMP list
lock Showing 1 of 2 compounds — the rest is available on a paid plan.
| IMP | Trials | Status | First start | Last start |
|---|---|---|---|---|
| Golimumab | 2 | Unknown | 2022-11-30 | 2022-11-30 |
Request feasibility information
Ask this centre about capacity, equipment and patient population.
Upgrade this site to Business Plan
Own the profile, publish your feasibility data and reach sponsors directly.
Is something out of date?
Tell us what needs correcting and we'll update this profile.
lock Available to Business plan sites only.